When psoriasis manifests in palmoplantar and intertriginous regions or on the nails, this often poses a therapeutic challenge. Several recently presented analyses on the effects of anti-IL-23p19 antibodies currently approved for psoriasis focused on patient populations with infestation of these difficult-to-treat body regions.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- DERMATOLOGIE PRAXIS
Related Topics
You May Also Like
- GLA:D® program for back pain patients
Fewer consultations and reduction in the use of painkillers
- Nutrition for type 2 diabetes
Not such a great tuber
- From symptom to diagnosis
Abdominal pain – external hernias
- Mechanisms, evidence and therapeutic consequences
GLP-1 receptor agonists in cardiology
- MASLD/MASH
Drug therapy options on the rise: spectacular evidence
- New ways of neuroregeneration
CRISPR and artificial intelligence
- Asbestos victims
Federal Council has decided to amend the UVG
- Music as a cure for cancer?